Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
June 2030 35
2030-06-01
Primary completion A Polypill for Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07032389
2030-06-01
Study completion Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07356284
2030-06-01
Primary completion Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07356284
2030-06-01
Study completion Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07736196
2030-06-01
2030-06-01
Study completion Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07938281
2030-06
Study completion Retina is a Marker for Cerebrovascular Heath Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04753970
2030-06
Primary completion Retina is a Marker for Cerebrovascular Heath Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04753970
2030-06
Study completion Pilot/Pivotal Study of DBS+Rehab After Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05701280
2030-06
Study completion Telerehabilitation In The Home After Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06682429
2030-06
Primary completion Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07084259
2030-06
Study completion Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07577739
2030-06
Primary completion A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07680829
2030-06
Study completion Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07688551
2030-06
Study completion Personalized Antiplatelet Therapy to Prevent Recurrent Cardiovascular Events in After Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07943026
2030-06-14
2030-06-15
Study completion Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT00117936
2030-06-15
2030-06-15
2030-06-27
Study completion TRISCEND II Pivotal Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04482062
2030-06-30
2030-06-30
2030-06-30
Study completion INSIGHTFUL-FFR Clinical Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05437900
2030-06-30
Study completion High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05845424
2030-06-30
Study completion Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06360458
2030-06-30
Study completion Stroke Prevention in Nigeria 2 Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06526117
2030-06-30
Primary completion Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07210606
2030-06-30
Study completion Ultralow Dose PET Imaging of 18F-flurpiridaz Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07284576
2030-06-30
Primary completion Ultralow Dose PET Imaging of 18F-flurpiridaz Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07284576
2030-06-30
Primary completion FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07332741
2030-06-30
2030-06-30
2030-06-30
2030-06-30
Primary completion Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07632898
2030-06-30
July 2030 20
2030-07-01
2030-07-01
2030-07
Study completion Proton Radiotherapy for Primary Central Nervous System Tumours in Adults Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT02797366
2030-07
2030-07
Primary completion Incremental Hemodialysis: The TwoPlus Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05828823
2030-07
Study completion Impact GLP-1 Agonists Following Bariatric Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06132477
2030-07
Study completion Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07084259
2030-07
2030-07
2030-07-08
Study completion Pentoxifylline in Diabetic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT03625648
2030-07-09
Primary completion Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04684602
2030-07-11
Study completion UBT251 Injection Phase II Clinical Study (CKD) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07134335
2030-07-11
Primary completion UBT251 Injection Phase II Clinical Study (CKD) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07134335
2030-07-18
Study completion Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06291376
2030-07-30
2030-07-31
Primary completion Heart Rate Regularization in Atrial Fibrilation and Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05029570
2030-07-31
2030-07-31
Study completion FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06409364
2030-07-31
Study completion A Polypill for Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07032389
2030-07-31
August 2030 13
2030-08-01
2030-08-01
Study completion Transcranial Direct Current Stimulation for Treatment of Acute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06440707
2030-08-01
Study completion kTMP in Chronic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07277595
2030-08-01
Primary completion kTMP in Chronic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07277595
2030-08
Primary completion Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07238972
2030-08
Primary completion Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07695701
2030-08
Study completion Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07754318
2030-08-06
Study completion LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07705594
2030-08-29
2030-08-30
Study completion Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04893291
2030-08-31
Study completion ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05686317
2030-08-31
Study completion Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07108985
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2026-02-01
Study completion Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices Registry record
Expected 2026-02-01; that period ended on 2026-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06652750
2026-02-01
Primary completion Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease Registry record
Expected 2026-02-01; that period ended on 2026-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07180745
2026-02-01
Study start Efficacy of Montelukast on STEMl Patients Registry record
Expected 2026-02-01; that period ended on 2026-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07320625
2026-02-01
2026-02-01
Study start VR Training to Improve Postoperative Cognitive Function in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery Registry record
Expected 2026-02-01; that period ended on 2026-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07370844
2026-02-01
Study start Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes Registry record
Expected 2026-02-01; that period ended on 2026-02-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07383155
2026-02-05
Study start DNV001 Injection in Patients With Hypercholesterolemia Registry record
Expected 2026-02-05; that period ended on 2026-02-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07391722
2026-02-12
Study start The Coronary Sinus Balloon Pump in STEMI Registry record
Expected 2026-02-12; that period ended on 2026-02-12.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07354035
2026-02-15
Study start Comparison of Available Standard Pulse Field Ablation Methods for Pulmonary Vein Isolation for Treatment of Atrial Fibrillation Registry record
Expected 2026-02-15; that period ended on 2026-02-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07456540
2026-02-20
Primary completion To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms Registry record
Expected 2026-02-20; that period ended on 2026-02-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06158087
2026-02-20
Primary completion Coronary Aspiration Catheter Clinical Trial Registry record
Expected 2026-02-20; that period ended on 2026-02-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06951724
2026-02-24
Study start A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Registry record
Expected 2026-02-24; that period ended on 2026-02-24.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07394114
2026-02-25
Study completion Preventing Hypoxia in Sedated TAVI: SuperNO₂VA vs. Conventional Oxygen Registry record
Expected 2026-02-25; that period ended on 2026-02-25.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07006064
2026-02-28
Study completion Social Determinants and a Diabetes Prevention Program Tailored for African Americans Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05301413
2026-02-28
Study completion Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05547165
2026-02-28
Primary completion Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05547165
2026-02
Study completion Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05825573
2026-02-28
Study completion Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06041529
2026-02-28
Primary completion Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06041529
2026-02-28
Primary completion To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06158750
2026-02
Primary completion FibriCheck Data Registry Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06282393
2026-02
Primary completion Evaluation of the Efficacy and Safety of Surgical Device Lymphoblock for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair. Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06286540
2026-02
Study completion A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06559722
2026-02
Primary completion A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06568471
2026-02
Study completion WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06752772
2026-02
Study completion Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06759272
2026-02
Primary completion Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06759272
2026-02
Primary completion A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07018453
2026-02-28
Study completion Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07064525
2026-02-28
Study completion A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07109700
2026-02-28
Study completion FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07174206
2026-02
Study start Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07181382
2026-02
Study start HEARTS in Sync + CardioWatch 287-2 Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07322510
2026-02-28
Study start Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II) Registry record
Expected 2026-02-28; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07343076
2026-02
Study start ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07371689
2026-02
2026-02
Study start Reversal to Normoglycemia by Treating Prediabetes Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07392151
2026-02
Study start Effect of Add-on L-Arginine Therapy on Heart Failure Patients Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07394270
2026-02
Study start Safety and Efficacy of the RENATUS® Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07414342
2026-02
Study start Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR Registry record
Expected 2026-02; that period ended on 2026-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07434661
2026-03-01
Study completion The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03840226
2026-03-01
Primary completion Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04892199
2026-03-01
Study completion Timely Recovery After Subclinical Heart Failure Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06341101
2026-03-01
Primary completion Timely Recovery After Subclinical Heart Failure Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06341101
2026-03-01
Study completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D ) Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06522282
2026-03-01
Study start Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06787430
2026-03-01
Primary completion Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06820567
2026-03-01
Study start Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07162363
2026-03-01
Study completion Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07180745
2026-03-01
Study start ArcFlex Sheath in TAVR Trial Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07320274
2026-03-01
Study start Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07347626
2026-03-01
Primary completion Blended Resources for Integrated Diabetes Guidance and Empowerment Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07373379
2026-03-01
Study start Blended Resources for Integrated Diabetes Guidance and Empowerment Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07373379
2026-03-01
Study start A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07373613
2026-03-01
2026-03-01
Study start Microwave Ablation for Treatment of Vascular Malformations: Efficacy and Safety Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07404670
2026-03-01
Study start Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD) Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07415642
2026-03-01
Study start Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07436182
2026-03-01
Study start Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07471282
2026-03-01
Study start Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window Registry record
Expected 2026-03-01; that period ended on 2026-03-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07476898
2026-03-02
Study start Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease Registry record
Expected 2026-03-02; that period ended on 2026-03-02.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07206290
2026-03-05
Study start QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Registry record
Expected 2026-03-05; that period ended on 2026-03-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07444086
2026-03-06
Study completion Thrombectomy In TANdem Occlusion Registry record
Expected 2026-03-06; that period ended on 2026-03-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03978988
2026-03-07
Primary completion Aggressive Smoking Cessation Trial (ASAP) Registry record
Expected 2026-03-07; that period ended on 2026-03-07.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05257629
2026-03-14
Study start A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire Registry record
Expected 2026-03-14; that period ended on 2026-03-14.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07054541
2026-03-15
Study completion Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke Registry record
Expected 2026-03-15; that period ended on 2026-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04675762
2026-03-15
Study start Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes Registry record
Expected 2026-03-15; that period ended on 2026-03-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07173712
2026-03-17
2026-03-18
Primary completion Combination of Hypothermia and Thrombectomy in Acute Stroke Registry record
Expected 2026-03-18; that period ended on 2026-03-18.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06301412
2026-03-20
Study start Lithotripsy Versus Balloon Angioplasty for Optimal Treatment of CAlcified Lesions With and Without Optical Coherence Tomography evaluatION Registry record
Expected 2026-03-20; that period ended on 2026-03-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07388030
2026-03-20
Study start Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial Registry record
Expected 2026-03-20; that period ended on 2026-03-20.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07485075
2026-03-22
Primary completion Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER). Registry record
Expected 2026-03-22; that period ended on 2026-03-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07055919
2026-03-23
Study start POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Registry record
Expected 2026-03-23; that period ended on 2026-03-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07469722
2026-03-25
Study start Efficacy and Safety of Intra-arterial Tenecteplase in Acute Ischemic Stroke Patients With Medium Vessel Occlusion Stroke (DATE-MeVO) Registry record
Expected 2026-03-25; that period ended on 2026-03-25.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07469293
2026-03-27
2026-03-30
Study completion Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04263922
2026-03-30
Study completion SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06442280
2026-03-30
Primary completion The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06501222
2026-03-30
Primary completion Nebivolol ANOCA Treatment Randomized Trial Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06755801
2026-03-30
Study completion The Effectiveness and Safety of the Coronary Artery Serrated Cutting Balloon Dilation Catheter in the Pre-dilation of Coronary Artery Stenosis Lesions Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06926400
2026-03-30
Study start Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07134712
2026-03-30
Primary completion A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07372326
2026-03-30
Study start Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07385209
2026-03-30
Primary completion Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes Registry record
Expected 2026-03-30; that period ended on 2026-03-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07452913
2026-03
Study start Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest Registry record
Expected 2026-03; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03176186
2026-03-31
Study completion Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03304496
2026-03-31
Study completion ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03462498
2026-03-31
Study completion STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03777631
2026-03-31
Primary completion STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03777631
2026-03
Study completion European Blood Pressure Intensive Control After Stroke Registry record
Expected 2026-03; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04647292
2026-03-31
Study completion Long-term Beta-blocker Therapy After Acute Myocardial Infarction Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04769362
2026-03-31
Study completion Eversense® Non-adjunctive Use Post Approval Study Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04836546
2026-03-31
Primary completion Eversense® Non-adjunctive Use Post Approval Study Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04836546
2026-03
2026-03
2026-03-31
Primary completion CardioPulmonary Resuscitation With Argon (CPAr) Trial Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05482945
2026-03-31
Study completion Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05604638
2026-03-31
Study completion Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 Registry record
Expected 2026-03-31; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05619653
2026-03
2026-03
Primary completion Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke Registry record
Expected 2026-03; that period ended on 2026-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06005233